Joel Farley, PhD, is an associate professor in the Division of Pharmaceutical Outcomes and Policy. His research concentrations are in the areas of pharmacoepidemiology and pharmaceutical outcomes. His primary research interest relates to the evaluation of the public policies used to manage prescription medications. In particular, Dr. Farley interested in the effect of Medicaid prescription cost-containment policies on vulnerable populations.
Dr. Farley has experience working with both primary and secondary data. He has particular expertise in the use of secondary data sources including the Medical Expenditure Panel Survey, private health plan data, and State Medicaid Research Files. Dr. Farley has publications ranging from methodological considerations in outcomes research to commentaries on public policy issues. However, his primary publication stream relates to examinations of the decision to use medications among select patient populations. These investigations are used to identify issues of effectiveness, access, and affordability of medications among different patient populations.